The National Institute of Mental Health has issued a five-year, $4 million grant that will be split equally between researchers at the Wayne State University School of Medicine and Boston University to explore the therapeutic benefits of the drug alloprenanolone as a...
PTSD
MSU Led Study Identifies Two New PTSD-related Biomarkers in Middle East War Refugees
A Michigan State University (MSU) professor completed a study identifying two biomarkers in recent Middle Eastern war refugees that appear to be related to post-traumatic stress disorder and other mental health problems. These are manifested by elevated levels of two...
Multi-National & Multi-Site PTSD-based Clinical Trial Leads to FDA Expansion of Access to Ecstasy
Because of successful clinical trials including those in Mount Pleasant, South Carolina conducted by therapist Michael Mithoefer, the Food and Drug Administration (FDA) have expanded the use of ecstasy guided therapy—known as MDMA—which is an illegal drug often...
Cohen Veterans Bioscience & Parexel’s New Emerging Biopharma Unit Ink Landmark Adaptive Clinical Program Targeting PTSD
Cohen Veterans Bioscience (CVB), a nonprofit research organization dedicated to fast-tracking personalized diagnostics and therapeutics for brain health, inked a strategic collaboration with Parexel Biotech, the clinical research organization’s (CRO) new division, for...
Center for Psychedelic Research Opens at Johns Hopkins Medicine
Johns Hopkins has opened The Center for Psychedelic and Consciousness Research in the nation’s first-ever research center to study the use of psychedelic substances as medicine for a range of mental health ailments, including addiction, depression, and PTSD. With $17...
University of Central Florida (UCF) Restores: Clinical Research Center Focusing on PTSD
University of Central Florida (UCSF) Restores, a clinical research center specializing in the treatment of post-traumatic stress disorder (PTSD), will launch therapy programs in three U.S. military installations in Fall 2019. These “pop-up” treatment programs are made...
The Landing: Awaiting FDA Approval to be the First MDMA Treatment Clinic in America for Treatment & Clinical Trials
MDMA is now recognized as a serious prospective cure for emotional trauma and a new clinic in Pennsylvania may become the first legally-sanctioned dedicated facility for using the psychoactive drug on treatment-resistant PTSD in the United States. Called the Landing,...
BioXcel Therapeutics Wins Award by U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP) for BXCL501 Development.
BioXcel Therapeutics (BTIAI) received a planning grant as part of its Alcohol and Substance Abuse Disorders Research Program (ADADRP) related to the development of the company’s investigational candidate BXCL501. The grant will support the development of a clinical...
Children with Immigrant Dads Suffer PTSD Disproportionately
The social determinants of health significantly impact the whole person. For example, a recent University of Turku, Finland study reveals that children with immigrant father are more likely to suffer from post-traumatic stress disorder (PTSD). The Finish...
NYU School of Medicine Research Reveals AI Can Diagnose PTSD with Voice Analysis
New York University School of Medicine researchers are in hot pursuit of demonstrating how Artificial Intelligence (AI) can detect post-traumatic stress disorder (PTSD) in veterans by analyzing their voices. A recent study published in Depression and Anxiety and...
Wake Forest Trial Reveals Cereset Tech Reduces PTSD Symptoms in Military Personnel
As published in Sleep Review Magazine, Wake Forest School of Medicine conducted a clinical trial that reveals that use of a noninvasive technology from the creators of Cereset reduces symptoms of military-related traumatic stress. Additionally, it may improve brain...
Columbia University Study Shows PTSD Symptoms Link to Risk of Hypertension
Columbia University Medical Center leads a study that was recently published in Psychological Medicine, suggesting that fear-related symptoms are a core driver of elevated cardiovascular risk. “A growing body of research research indicates that PTSD is associated with...
Yale & Icahn Study Links PTSD to Brain Properties
Matt Kristoffersen writing for Yale Daily News reports that both Yale University and the Icahn School of Medicine, Mount Sinai have teamed up to study how post-traumatic stress disorder impacts the brain. The researchers are measuring how combat veterans react...